Stay updated on OMS721 in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the OMS721 in IgA Nephropathy Clinical Trial page.

Latest updates to the OMS721 in IgA Nephropathy Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedUpdated page now publicly states funding-related operational notices and current version (v3.2.0), while removing a prior resource entry (IgA glomerulonephritis) and referencing the newer revision.SummaryDifference3%
- Check24 days agoChange DetectedContent taxonomy update: broad saline/solution terms are removed and specific chemical categories and Sodium Chloride-related entries are added, with a version bump from v3.0.2 to v3.1.0.SummaryDifference0.6%
- Check39 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the Back to Top element was removed, with no substantive content changes otherwise.SummaryDifference0.1%
- Check46 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%
- Check53 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations, as well as updated drug information related to chronic kidney disease and IgA nephropathy. Notably, the previous version's references to certain locations and genetic resources have been removed.SummaryDifference10%
- Check67 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to OMS721 in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OMS721 in IgA Nephropathy Clinical Trial page.